Methionine, Homocysteine, and Methylation Levels Predict Cognitive Decline in Alzheimer's Disease
CNS Neuroscience & Therapeutics · 2026-06 · 32 (6)
DOI: 10.1002/cns.70954 ↗Kurz gefasst
Fachartikel in der Zeitschrift CNS Neuroscience & Therapeutics, online erschienen am 27.05.2026. Verfasst von Xiaoyu Zhang und 8 weiteren Autor:innen. Beteiligte Einrichtung: Department of Neurology, Renji Hospital, Shanghai Jiaotong University School of Medicine, Shanghai, China. Hauptthemen laut MEDLINE: Homocysteine, Alzheimer Disease, Methionine, Cognitive Dysfunction. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 28 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Natural Science Foundation of Hebei Province, National Natural Science Foundation of China, NIA NIH HHS.
Themen: Demenz
Abstract (Originalsprache)
Background
Alzheimer's disease (AD), the most common cause of dementia, involves metabolic factors such as homocysteine, methionine, and DNA methylation in its pathogenesis. However, the precise interactions among these factors and their impact on cognitive function in AD require further elucidation.
Methods
A total of 191 AD patients and 200 cognitively normal (CN) individuals were selected from the Alzheimer's Disease Neuroimaging Initiative (ADNI) database. Demographic, clinical, and metabolic data, including MMSE scores and white matter hyperintensity (WMH) volumes, were collected. Longitudinal cognitive changes over 1 year were also evaluated in 104 AD patients.
Results
Compared to CN subjects, AD patients exhibited significantly lower MMSE scores, hippocampal volume, total brain volume, methionine levels, and methylation levels, alongside higher homocysteine levels and WMH volumes. Logistic regression and correlation analyses revealed that homocysteine, methionine, and methylation levels were significantly associated with cognitive function in AD patients but not in CN subjects. Elevated homocysteine levels in AD patients correlated with lower MMSE scores, higher WMH volumes, lower vitamin B12 levels, and older age. Similarly, low methionine and methylation levels were associated with more severe cognitive impairment and brain atrophy. Longitudinal analyses showed that AD patients with low methionine, high homocysteine, or low methylation levels experienced significantly greater cognitive decline over 1 year compared to those with more favorable biomarker profiles.
Conclusions
Our findings highlight the significant associations between homocysteine, methionine, and methylation levels and cognitive decline in AD patients. These results suggest that metabolic and epigenetic alterations may contribute to AD progression and could serve as potential biomarkers or therapeutic targets in AD.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Neurology, Renji Hospital, Shanghai Jiaotong University School of Medicine, Shanghai, China.
- Department of Neurology, The First Hospital of Hebei Medical University, Brain Aging and Cognitive Neuroscience Laboratory of Hebei Province, Shijiazhuang, China.
- Hebei Key Laboratory of Integrative Medicine on Liver-Kidney Patterns, College of Integrative Medicine, Institute of Integrative Medicine, Hebei University of Chinese Medicine, Shijiazhuang, China.
ORCID-Profile: Xiaoyun Liu, Hualong Wang
Förderung
- Natural Science Foundation of Hebei Province
- National Natural Science Foundation of China
- NIA NIH HHS
- Government-funded Outstanding Clinical Medical Talent Training Program
- Science and Technology Research Project for Higher Education Institutions in Hebei Province
Zitieren
APA
Zhang, X., Guan, A., Li, W., Zhao, Z., Tang, L., Yao, X., Liu, X., Wang, G., & Wang, H. (2026). Methionine, Homocysteine, and Methylation Levels Predict Cognitive Decline in Alzheimer's Disease. CNS Neuroscience & Therapeutics, 32(6). https://doi.org/10.1002/cns.70954
Vancouver
Zhang X, Guan A, Li W, Zhao Z, Tang L, Yao X, et al. Methionine, Homocysteine, and Methylation Levels Predict Cognitive Decline in Alzheimer's Disease. CNS Neuroscience & Therapeutics. 2026;32(6). doi:10.1002/cns.70954
BibTeX
@article{Zhang2026,
author = {Zhang, Xiaoyu and Guan, Ai and Li, Wanlin and Zhao, Zhenbo and Tang, Liufeng and Yao, Xiaoguang and Liu, Xiaoyun and Wang, Gang and Wang, Hualong},
title = {Methionine, Homocysteine, and Methylation Levels Predict Cognitive Decline in Alzheimer's Disease},
journal = {CNS Neuroscience & Therapeutics},
year = {2026},
volume = {32},
number = {6},
doi = {10.1002/cns.70954}
}
EUVIMED